InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Martell Christopher, Directeur. Officer active across 1 company, notably Candel Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €10k. History available since 8 December 2022. The latest transaction was disclosed on 25 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Christopher Martell is a Director at Candel Therapeutics, Inc. He plays a crucial role in overseeing operations and the company's strategy, contributing to its development and innovation. His expertise in the biopharmaceutical sector is valuable to the board.